NCT06451380View on ClinicalTrials.gov

Patient-controlled Sedation With Propofol Versus Anesthesiologist-administered Sedation for Orthopedic Surgery

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 2, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Orthopedic Disorder
Interventions
PROCEDURE

orthopaedic surgery

orthopaedic surgery of the upper limb under anaesthesia

DRUG

propofol anesthesia

The initial dose of propofol and the refractory period will be determined according to a standardized protocol used in current practice.

Trial Locations (1)

75016

RECRUITING

Clinique Jouvenet, Paris

Sponsors

Collaborators (1)

Euraxi Pharma
All Listed Sponsors
collaborator

Euraxi Pharma

INDUSTRY

lead

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER

NCT06451380 - Patient-controlled Sedation With Propofol Versus Anesthesiologist-administered Sedation for Orthopedic Surgery | Biotech Hunter | Biotech Hunter